Bioinformatic analysis of microRNA expression in Huntington's disease

Xiaoyu Dong1, Shuyan Cong1

  • 1Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.

Insights

This study identifies a pattern of microRNAs (miRNAs) involved in Huntington's disease (HD) pathogenesis. Key miRNAs like hsa‑miR‑4488, hsa‑miR‑196a‑5p, and hsa‑miR‑549a show potential as therapeutic targets for this inherited neurodegenerative disorder.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Bioinformatics

Background:

  • Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a CAG expansion in the Huntingtin (HTT) gene.
  • The precise pathogenesis of HD, despite its monogenic origin, remains incompletely understood.
  • Identifying molecular patterns, such as microRNA (miRNA) involvement, is crucial for understanding HD progression.

Purpose of the Study:

  • To identify a synergistic microRNA (miRNA) expression pattern associated with Huntington's disease (HD).
  • To explore the potential role of identified miRNAs and their target genes in HD pathogenesis.
  • To investigate potential therapeutic targets for HD based on miRNA-mRNA interactions.

Main Methods:

  • Downloaded and analyzed miRNA (GSE64977) and gene expression (GSE64810) datasets.
  • Utilized R programming for identifying differentially expressed genes (DEGs) and differentially expressed miRNAs (DEMs).
  • Employed TargetScan for miRNA target prediction, FunRich for Gene Ontology (GO) analysis, and Cytoscape for network construction.

Main Results:

  • Identified 1,612 DEGs and 10 DEMs.
  • GO analysis of DEGs highlighted roles in inflammatory and immune responses.
  • A network analysis revealed 33 overlapping genes between DEM targets and DEGs, implicating hsa‑miR‑4488, hsa‑miR‑196a‑5p, and hsa‑miR‑549a.

Conclusions:

  • The study successfully identified a miRNA-mRNA interaction network relevant to HD pathogenesis.
  • Specific miRNAs, including hsa‑miR‑4488, hsa‑miR‑196a‑5p, and hsa‑miR‑549a, are implicated in HD.
  • These findings suggest potential novel therapeutic targets for Huntington's disease.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...